Semechkin Rouslan

Avg. Two Year Performance

(30%) Avg. Purchase Return
(14%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(13%)(29%)(24%)(71%)(30%)
Purchase Success Rate0 of 30 of 31 of 30 of 30 of 3
Average Sale Return----------
Sale Success Rate----------
Drugs » Biotechnology

EVP and CSO, Director, 10% Owner:

Holdings: 178.4K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--